Early phase I study of non-viral CD19/CD22/BCMA tri-targeting JL-Lightning-CAR-T in relapsed/refractory B-cell non-Hodgkin's lymphoma.Jinxing Lou, Qijun Qian, Yan Sun et al.|Journal of Clinical Oncology|2025Cited by 0